NCT00979628 - Basal Bolus Versus Basal Insulin in Type 2 Diabetes Mellitus (T2DM) | Biotech Hunter

Enrollment

375

Participants

Timeline

Start Date

January 31, 2010

Primary Completion Date

March 31, 2012

Study Completion Date

June 30, 2012

Conditions

Type 2 DiabetesHyperglycemia

Interventions

DRUG

sliding scale regular insulin (SSRI)

four-time daily in patients with T2DM admitted to general medicine and surgery wards.

DRUG

Basal Bolus

glargine once daily plus glulisine before meals (plus corrective doses of glulisine as needed)

DRUG

Basal Plus

glargine once daily plus corrective doses of glulisine before meals and bedtime as needed

Trial Locations (5)

Atlanta VA Medical Center, Decatur

Grady Memorial Hospital, Atlanta

Emory University Hospital, Atlanta

Scott & White Memorial Hospital and Clinic, Temple

Medical University of South Carolina, Charleston